Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences (TSE:DRUG)
:DRUG
RESEARCH TOOLSreports
Total Valuation
Bright Minds Biosciences has a market cap or net worth of C$299.86M. The enterprise value is C$239.48K.
Market CapC$299.86M
Enterprise ValueC$239.48K
Share Statistics
Bright Minds Biosciences has 7.04M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7.04M
Owened by Insiders30.50%
Owened by Instutions54.65%
Financial Efficiency
Bright Minds Biosciences’s return on equity (ROE) is -1.12 and return on invested capital (ROIC) is -110.42%.
Return on Equity (ROE)-111.73%
Return on Assets (ROA)-107.17%
Return on Invested Capital (ROIC)-110.42%
Return on Capital Employed (ROCE)-111.65%
Revenue Per Employee―
Profits Per Employee-C$∞
Employee Count0
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bright Minds Biosciences is -1.08. Bright Minds Biosciences’s PEG ratio is 0.02.
PE Ratio-1.08
PS Ratio0.00
PB Ratio1.21
Price to Fair Value1.21
Price to FCF-1.14
Price to Operating Cash Flow-1.14
PEG Ratio0.02
Income Statement
In the last 12 months, Bright Minds Biosciences had revenue of C$0.00 and earned -C$1.07M in profits. Earnings per share was -C$0.24.
RevenueC$0.00
Gross Profit-C$36.23K
Operating Income-C$319.96K
Pretax Income-C$1.07M
Net Income-C$1.07M
EBITDA-2.68M
Earnings Per Share (EPS)-0.24
Cash Flow
In the last 12 months, operating cash flow was -C$2.52M and capital expenditures C$0.00, giving a free cash flow of -C$2.52M billion.
Operating Cash Flow-C$2.52M
Free Cash Flow-C$2.52M
Free Cash Flow per Share-C$0.36
Dividends & Yields
Bright Minds Biosciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-87.85%
Earnings Yield-92.20%
Stock Price Statistics
Beta25.19
52-Week Price Change2480.00%
50-Day Moving Average51.72
200-Day Moving Average34.66
Relative Strength Index (RSI)51.43
Average Volume (3m)636.00
Important Dates
Bright Minds Biosciences upcoming earnings date is May 14, 2025, After Close.
Last Earnings DateFeb 13, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Bright Minds Biosciences as a current ratio of 24.26, with Debt / Equity ratio of 0.01
Current Ratio24.26
Quick Ratio24.26
Debt to Market Cap0.00
Net Debt to EBITDA0.92
Interest Coverage Ratio-373.00
Taxes
In the past 12 months, Bright Minds Biosciences has paid -C$2.00 in taxes.
Income Tax-C$2.00
Effective Tax Rate0.00%
Enterprise Valuation
Bright Minds Biosciences EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -0.19.
EV to Sales0.00
EV to EBITDA-0.18
EV to Free Cash Flow-0.19
EV to Operating Cash Flow-0.19
Balance Sheet
Bright Minds Biosciences has C$57.90M in cash and marketable securities with C$182.73K in debt, giving a net cash position of -C$57.71M billion.
Cash & Marketable SecuritiesC$57.90M
Total DebtC$182.73K
Net Cash-C$57.71M
Net Cash Per Share-C$8.19
Tangible Book Value Per ShareC$1.77
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bright Minds Biosciences is C$123.98, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$123.98
Price Target Upside191.24%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast86.45%